Ronadip R. Banerjee, MD, PhD
![[Ronadip R. Banerjee, MD, PhD]](/sites/default/files/styles/az_medium/public/2026-02/Banerjee-Ronadip-D-PhD_ENDO_Lab-Microscope_8x10.jpg.webp?itok=JTn8Ifd6)
AHSC Room 7432
Banner Appointments
Dr. Ronadip (Ron) Banerjee joined the University of Arizona faculty as chief of the Division of Endocrinology, Diabetes & Metabolism in 2026. Previously, Dr. Banerjee was on the faculty at the Johns Hopkins School of Medicine, University of Alabama at Birmingham (UAB) School of Medicine, and Stanford University School of Medicine. While at Stanford, he also was an attending physician at the VA Palo Alto Health Care System.
Dr. Banerjee’s clinical interests include adrenal, pituitary, thyroid and parathyroid disorders. He has expertise in Endocrine Tumors including pancreatic and neuroendocrine tumors, Multiple Endocrine Neoplasia, and adrenal nodules.
His awards include the Junior Faculty Development Award from the American Diabetes Association, and the Pittman Scholar Award (from UAB), amongst others.
Degrees
- MD: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 2005
- PhD: University of Pennsylvania School of Medicine, Philadelphia, Cell and Molecular Biology, 2003
- BS (Biological Sciences): Stanford University, Stanford, California, 1997
Dr. Banerjee’s research is focused on hormonal regulation of metabolism in health and disease. A major focus of the lab is pancreatic islets, including the insulin-producing beta-cells, and how they adapt to physiologic stressors such as pregnancy or dietary changes, and display maladaptive responses in diseases such as diabetes. The Banerjee lab has showed a critical role for prolactin receptor (PRLR) signaling in pregnancy adaptation and has identified downstream signal transduction and molecular targets of PRLR signaling responsible for adaptive changes in beta-cells. Current work is investigating how specific targets may contribute to gestational diabetes.
His research funding sources have included the American Diabetes Association and the National Institute of Diabetes and Digestive and Kidney Diseases, and Eunice Kennedy Shriver National Institute of Child Health and Human Development, both units of the National Institutes of Health.
He has served as an associate editor of Frontiers in Endocrinology, and is currently a review editor for the journal. In addition, he has served as a peer reviewer for multiple other journals including Endocrinology, Molecular and Cellular Endocrinology, Diabetes, AJP Endocrinology and Metabolism, Journal of Endocrinology, Endocrine Reviews, Journal of Clinical Endocrinology and Metabolism, Molecular Metabolism Scientific Reports, Metabolites, BMJ Open Diabetes Research & Care, Nature Metabolism, Cell Reports, Cell Genomics, and Nature Communication.